~~<i id='F9D3D82EA8'><strike id='F9D3D82EA8'><tt id='F9D3D82EA8'><pre id='F9D3D82EA8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：explore 2025-08-23 06:47:04 - browse：5

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Manchin plays down potential 3rd

Wikipedia

explore

focus

explore

leisure time

entertainment

HyacinthEmpinado/STATWhendermatologistJennaLesterlearnedthatrashesonskinandtoeswereasymptomofCovid-1

WSS

How Long Island became the ‘eugenics capital of the world’

In science, is the line between industry and academia shifting?

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Medicare explains how it will choose drugs for negotiation

Radiation, mainstay of cancer treatment, begins a fade

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

hotspot

hotspot

Wikipedia

Virginia high school admissions case could be legal follow

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Wildfire smoke exposes gaps in outdoor worker protections

Appeals court upholds limits to abortion pill

Walensky prepares to leave CDC — and Congress — behind

Apellis safety probe of eye disease drug centers on injection needle

The cancer drug shortage isn’t new — and neither are the solutions

US soldier in North Korean custody after crossing DMZ line

The high cost of giving birth even with insurance

BridgeBio heart drug succeeds in pivotal study

explore

BridgeBio heart drug succeeds in pivotal study

Study: Hearing aids may slow cognitive decline in those at risk

CDC advisory panel says seniors 'may' get RSV vaccine

Study finds new variant for Parkinson’s in African populations

FDA seeking to stop procedures at two unregulated stem cell clinics

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

focus

explore

leisure time

entertainment